You are here

News

2012

Dra. Ma. del Consuelo Mancias Guerra
Oct 2012   Our clinical trial, listed as ClinicalTrials.gov NCT01019733, was carried out at a University Hospital in Monterrey, Mexico, where we treated children with cerebral palsy that were not able to bank their cord blood. Instead we use stem cells derived from their bone marrow.
Aby J. Mathew, PhD
Oct 2012   Being able to keep the important stem cells in cord blood and birth tissues alive and stored for a long period of time is the key to the utility of "banking" them for later use. This is achieved by freezing, or cryopreservation, of the cells; but how to effectively accomplish this is a bit more complicated than as if storing leftovers in the kitchen freezer.
Doug Sipp
Sep 2012   Great hopes and anticipation have surrounded umbilical cord blood-derived cells since their first clinical use in the 1980s. They represent a relatively rich source of hematopoietic stem cells (HSCs), which are capable of restoring the blood system following disease, chemotherapy, or radioablation. Today HSCs from cord blood are widely used in the treatment of diseases of the blood system. Various other cell types derived from perinatal tissues, such as placenta, amniotic fluid, and Wharton's jelly, are also being examined for potential clinical uses. But the great excitement surrounding these sources of stem cells has also led to the rapid and uncontrolled development of an industry that markets unsupported and outright dubious "stem cell treatments" direct to patients and their families, charging thousands to tens of thousands of dollars for these unproven interventions.
Save The Cord Foundation
Sep 2012   Save the Cord Foundation is working to make the collection of cord blood the standard of public health education and care in hospitals throughout the nation. Save the Cord Foundation is a 501c3 nonprofit organization established to advance cord blood awareness, education, research and legislation, and to provide free, unbiased, factual information to expectant parents and the public surrounding the medical value and life-saving benefits of umbilical cord blood and its storage options.
Dennis Todd, PhD
Sep 2012   You've just visited the doctor and the good news is that you're going to have a baby and everything looks good. Thirty years ago, your doctor may have given you a baby book and information about products that sponsors want you to buy for your new addition. Today, along with pretty much the same materials, you'll be asked to consider saving the blood of your newborn that's left over in the umbilical cord and placenta after the delivery. Another big decision, and possibly a costly one.
Pamela S. Becker, MD PhD
Aug 2012   Fanconi anemia is an inherited disorder where patients have a defect in their ability to repair damaged DNA. It leads to progressively lower levels of blood cells and higher chances for developing acute leukemia or other cancers. The treatments available today include medications or transfusions to increase the patient's blood counts. The only potential cure for the low blood counts in Fanconi anemia is a bone marrow transplant from a person who does not carry the disorder. However, not all patients have a suitably matched donor for a bone marrow transplant, and the transplant is a very risky procedure for Fanconi anemia patients.
David and Lynn Frohnmayer with daughter Amy
Aug 2012   Three of the Frohnmayers' five children were diagnosed with Fanconi Anemia. They created the nonprofit Fanconi Anemia Research Fund in 1989 to find effective treatments and a cure for Fanconi Anemia, and to provide education and support services to affected families worldwide.
Jordan H. Perlow, MD
Aug 2012   The unfortunate "state of the weight" in the United States is that over the past 50 years, the number of Americans classified as overweight or obese has climbed from 13% to two-thirds. Of particular importance to women's health care practitioners is the fact that more than 40% of pregnant women are either overweight or obese.
Jul 2012   The maternal and family health questionnaires that mothers usually complete before the collection of their baby's cord blood are designed to safeguard the health of the cord blood recipient. These questionnaires are an important component of the health evaluation, along with the testing of the maternal blood sample for infectious disease markers.
Jul 2012   Leukemia is a random killer. It can strike any one of us at any time. But for many, there is hope of a cure through a bone marrow, blood stem cell or umbilical cord blood transplant. That is, of course, if a suitable donor - including cord blood - can be found. Headquartered in Boca Raton, Florida, Gift of Life is one of the nation's public blood cell registries facilitating transplants for children and adults suffering from leukemia, lymphoma, other cancers and genetic diseases.